A&G PHARMACEUTICAL, INC.
A&G PHARMACEUTICAL, INC. is a federal contractor, registered under UEI SN6SWFABJXL1 and CAGE code 1T9L5. It has been awarded $11,591,136 across 85 federal contracts. Primary work spans Unknown NAICS, Research and Development in Biotechnology, and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services and Other agencies (4 agencies, <0.5% each).
Contact Information
Registration and classification details
Registration
UEI Code
SN6SWFABJXL1CAGE Code
1T9L5Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
A&G PHARMACEUTICAL, INC. specializes in end-to-end biopharmaceutical research and development, with deep expertise in monoclonal and polyclonal antibody generation, recombinant protein engineering, and precision biological manufacturing. The company delivers critical support in target validation, ce...
A&G PHARMACEUTICAL, INC. specializes in end-to-end biopharmaceutical research and development, with deep expertise in monoclonal and polyclonal antibody generation, recombinant protein engineering, and precision biological manufacturing. The company delivers critical support in target validation, cell line development, fusion and cloning technologies, and GMP-compatible production of therapeutic biologics, including antibody conjugates and engineered protein variants. Their technical capabilities span molecular biology, immunoassay development, and analytical characterization of biotherapeutics, with demonstrated success in advancing novel candidates against complex targets such as ACE2 truncations, FGF1 mutants, and glycol-chitosan nanoparticles. A&G distinguishes itself through its ability to bridge discovery-stage research with scalable manufacturing processes, ensuring seamless transition from preclinical proof-of-concept to candidate material production. The contractor maintains a sustained, primary relationship with the Department of Health and Human Services, delivering specialized R&D and manufacturing services across NIH and CDC-supported programs. Their work consistently supports infectious disease therapeutics, immunological target characterization, and biologics development for public health emergencies, reflecting a trusted role in mission-critical biomedical initiatives. A&G’s industry focus centers on biotechnology research (NAICS 541714), life sciences R&D (541715), and pharmaceutical manufacturing (325412 and 325414), positioning them as a niche provider for government-funded projects requiring integrated discovery-to-production workflows. They serve the biopharma and federal biomedical research sectors with tailored solutions for antibody therapeutics, peptide synthesis, and biological material production. As a small business structured as a 2L entity based in Columbia, Maryland, A&G PHARMACEUTICAL, INC. operates without federal certifications but maintains a focused presence in the federal life sciences contracting space, delivering high-complexity, compliance-driven services to U.S. health and research agencies.
Key Performance Metrics
Awards Count
All time
Active
Currently performing
Completed
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
